Last reviewed: June 9, 2026
Last updated: June 9, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide has emerged as one of the most effective weight-loss medications available, with clinical trials showing patients lose 10-15% of body weight on average. This injectable GLP-1 medication works by slowing digestion, increasing feelings of fullness, and reducing food cravings. PlexusDx provides access to compounded semaglutide from licensed 503A pharmacies across all 50 states, starting at $149 per month with no membership fees or insurance needed.
How Semaglutide Works for Weight Loss
Semaglutide activates GLP-1 receptors in the brain and digestive system, triggering signals that tell your body it's full and satisfied with less food. The medication slows stomach emptying, meaning you stay fuller longer after eating smaller portions. It also reduces hunger hormones and decreases cravings for high-calorie foods, making dietary changes feel more sustainable.
Unlike stimulant-based weight-loss drugs, semaglutide works with your body's natural appetite regulation pathways rather than against them. This mechanism makes it effective for patients who struggle with constant hunger or emotional eating. Studies show the weight loss continues as long as patients take the medication consistently.
Expected Results and Timeline for Weight Loss
Most patients begin seeing measurable weight loss within 4-6 weeks of starting semaglutide, though individual results vary based on starting dose, genetics, and lifestyle factors. By 16 weeks, many patients report losing 5-10% of their starting body weight. Continued treatment over 6-12 months typically results in 10-15% total body weight loss, with some patients achieving greater reductions.
Weight loss plateaus are normal and don't indicate treatment failure; they reflect your body reaching a new equilibrium at a lower set point. Plateaus may last weeks or months before additional weight loss resumes. PlexusDx patients with variable response rates may benefit from the Precision Peptide Genetic Test to identify individual peptide-pathway sensitivities and optimize medication selection.
Common Side Effects and How to Manage Them
Nausea is the most frequently reported side effect, typically occurring when doses increase or with high-fat meals, and usually improves within 1-2 weeks as your body adjusts. Other common effects include mild constipation, appetite suppression (the desired effect), fatigue, and occasional dizziness. Most side effects are temporary and manageable through dose adjustments, dietary modifications, or time.
Starting at the lowest effective dose and increasing gradually over weeks or months minimizes nausea and allows your body to adapt. Eating smaller, lower-fat meals and staying hydrated help reduce gastrointestinal symptoms. Serious side effects are rare; report persistent severe nausea, pancreatitis signs (severe abdominal pain), or allergic reactions to your healthcare provider immediately.
PlexusDx Semaglutide: Access, Pricing, and Personalization
PlexusDx offers compounded semaglutide injections starting at $149 per month through licensed 503A compounding pharmacies, with no insurance requirement, no membership fees, and HSA/FSA eligibility. Your dose may need to go up during treatment, but your monthly price won't change—transparency in cost is a core PlexusDx principle. Delivery is available to all 50 states, making high-quality compounded GLP-1 therapy accessible regardless of location or insurance status.
For patients seeking precision-guided medication selection, PlexusDx offers the Precision Peptide Genetic Test as a $99 add-on after the first month of treatment. This peptide-pathway genetic analysis maps 14 biological pathways, 49 peptides, and 150+ genetic insights—including variants in GLP1R, GIPR, FTO, and MC4R—to help determine whether semaglutide or dual-compound options may be most effective for your individual metabolism and appetite regulation profile.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How much weight can I expect to lose on semaglutide?
Clinical trials show average weight loss of 10-15% of starting body weight over 6-12 months, though individual results depend on dose adherence, diet, exercise, and genetic factors. Some patients lose more; others lose less. PlexusDx offers the Precision Peptide Genetic Test to help predict your personal response likelihood based on peptide-pathway genetics.
Is compounded semaglutide as effective as brand-name Ozempic or Wegovy?
Compounded semaglutide from licensed 503A pharmacies contains the same active ingredient and works through identical biological mechanisms as brand medications. Effectiveness depends on dose, consistency, lifestyle, and genetics—not the source of the compound. PlexusDx medications come from licensed compounding pharmacies meeting strict quality and purity standards, without FDA approval claims that would be illegal.
Why does PlexusDx keep the same price as my dose increases?
PlexusDx pricing is flat per medication, not per dose—you pay $149/month for compounded semaglutide regardless of whether you're at 0.25mg or 2.4mg weekly. This "your dose may need to go up, your price won't" model removes cost anxiety and encourages patients to reach their effective therapeutic dose without financial barriers.
What happens if I stop taking semaglutide—will I regain the weight?
Weight regain is common after stopping semaglutide because your body's appetite regulation returns to baseline. Many patients maintain some weight loss and lifestyle changes if they continue healthy eating and exercise. Long-term treatment is often needed to sustain results; discuss duration and exit strategies with your healthcare provider.
Can the PlexusDx Precision Peptide Genetic Test predict if semaglutide will work for me?
The Precision Peptide Genetic Test analyzes 14 pathways including GLP1R and GIPR variants to assess your biological response potential to GLP-1 medications like semaglutide. While genetics influence appetite and metabolism, lifestyle, dose, and adherence also matter significantly. The test helps optimize medication choice and guide expectations rather than guarantee outcomes.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Do GLP-1 Shots Work? Exploring the Efficacy of GLP-1 Medications for Weight Loss
Does Ozempic Help With Covid: New Research on GLP-1 Benefits